By Timothy S. Donahue

Top Takeaways:

• Growth engine: Modern Oral sales surged triple digits in Q1
• Investment phase: Margins compressed as TPB ramps marketing and manufacturing
• Long-term target: Company aims for double-digit pouch market share by 2030

Turning Point Brands is spending aggressively to carve out a larger share of the modern oral nicotine category. Its investors appear willing to tolerate near-term margin pressure for a bigger shot at long-term pouch market share.

The company reported first-quarter 2026 consolidated revenue of $124.3 million, up 17% year over year, driven largely by explosive growth in its Modern Oral segment, anchored by the FRE and ALP nicotine pouch brands. Adjusted earnings per share came in at US$0.76, well above analysts’ expectations of US$0.57, helping push TPB shares higher in premarket trading after the earnings release.

The biggest story was the modern oral nicotine category.

Segment net sales rose 133% year over year to $52 million, while gross sales surged 167% to $69 million, according to the company’s presentation. TPB said the category now accounts for 42% of the company’s net sales, underscoring how rapidly nicotine pouches are reshaping its business model.

Management framed the opportunity as part of a “greater than $50 billion generational shift in nicotine consumption post-cigarette,” while outlining ambitions to achieve a double-digit nicotine pouch market share by 2030.

“The outsized share of DTC sales coupled with share gains in retail indicates the plan is working in early stages,” the company said in its investor presentation.

At the same time, rapid expansion is weighing on profitability. Adjusted EBITDA declined 6.5% to $25.9 million, while the EBITDA margin fell from 26% to 20.8% as TPB invested in sales expansion, marketing and manufacturing infrastructure.

The company is also expanding a Louisville manufacturing facility to improve supply chain control and reduce freight and tariff exposure over time. Management said the strategy focuses on three priorities: building consumer traction, accelerating retail distribution, and scaling infrastructure.

As part of that push, TPB said ALP is moving into retail distribution faster than originally planned, while FRE continues to expand into larger regional and national chains. The company expects chain-store door count growth of roughly 70% by the end of 2026, compared with 2025 levels.

TPB also expanded FRE’s marketing partnership with TKO Group properties, including UFC, Zuffa Boxing, and Professional Bull Riders, as part of broader brand-building efforts. Meanwhile, legacy businesses are increasingly providing financial support for the pouch expansion.

“Legacy Stoker’s brands continue to provide support for investments,” management said.

The company’s Zig-Zag segment reported a 22% revenue decline, partly tied to the unwinding of the Clipper relationship and to resource reallocation toward Modern Oral, though gross margins improved.

TPB finished the quarter with $192.4 million in cash, though free cash flow turned negative as the company increased investment spending and working capital needs tied to growth. Despite that, management significantly raised full-year 2026 guidance.

Modern Oral gross sales guidance increased to $280 million to $300 million, up from a prior range of $220 million to $240 million. Net sales guidance also increased to $210 million to $225 million. The company also provided full-year adjusted EBITDA guidance of $70 million to $90 million.